Find Academic Supervisors

• Alzheimer's Disease
• Translational Neuroscience
• Memory Research
• +5 more

Heikki Tanila is a Professor of Translational Neuroscience and Deputy Head of Department at the A.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences, University of Eastern Finland. He leads the Neurobiology of Memory Research group, focusing on cellular mechanisms that mediate selective loss of recent memory in early Alzheimer's Disease. His work bridges basic neuroscience with clinical applications, particularly in neurodegenerative disorders. Professor Tanila's research interests center on Alzheimer's disease mechanisms, memory dysfunction, and translational neuroscience. His work extensively utilizes animal models, particularly transgenic mouse models of Alzheimer's disease, to investigate the cellular and molecular basis of memory loss. He employs sophisticated techniques including electrophysiology, behavioral testing, neuroimaging (particularly fMRI), and molecular analyses to understand disease progression and identify potential therapeutic targets. His research has made significant contributions to understanding the relationship between amyloid pathology, tau pathology, and cognitive decline. Analysis of Professor Tanila's recent publications reveals a strong focus on Alzheimer's disease mechanisms and potential interventions. His work spans from basic investigations of cellular mechanisms in memory loss to translational studies examining potential therapeutic approaches including immunotherapy, metabolic interventions, and genetic modifications. A notable trend is the increasing integration of advanced imaging techniques with traditional behavioral and molecular approaches to provide comprehensive understanding of disease processes. His research often examines the intersection between different pathological processes in Alzheimer's disease, including amyloid and tau pathology, neuroinflammation, and metabolic dysfunction. Professor Tanila maintains an active research program with numerous ongoing projects, including the Neuro-Innovation project (2021-2026) and the NOVEL MSCA Postdoctoral Programme (2024-2029). His laboratory, the Neurobiology of Memory Research group, represents a significant center for Alzheimer's disease research in Finland, contributing to both national and international collaborative efforts in understanding and treating neurodegenerative disorders.

• Tropical Medicine
• Parasitology
• Antibiotic Development
• +4 more

Prof. Dr. Achim Hörauf serves as Deputy Site Spokesperson for Bonn-Cologne and Deputy Coordinator for Malaria and Neglected Tropical Diseases at the University Hospital Bonn, part of the University of Bonn. His work spans multiple German research networks including DZIF sites in Bonn-Cologne, Hanover-Braunschweig, Gießen-Marburg-Langen, Hamburg-Lübeck-Borstel-Riems, Heidelberg, Munich, and Tübingen. His research focuses on Tropical Medicine and Parasitology , particularly: Development of macrofilaricidal drugs targeting Wolbachia River blindness (Onchocerca volvulus) treatment Neglected tropical diseases including lymphatic filariasis Antibiotic discovery for nematode infections Immune responses in helminth infections Recent publications demonstrate strong trends in Wolbachia-targeting antibiotics (notably Corallopyronin A), drug delivery systems, and immunological studies of filarial infections. His team has advanced Corallopyronin A to Phase I studies for river blindness treatment, addressing critical needs for drugs that kill adult worms infecting 21+ million Africans. Hörauf actively collaborates across Germany's major tropical medicine research centers, with recent work examining vaccine responses in dialysis patients and immune modulation in co-infections.

Marina Venero GalanternikView profile

Assistant Professor

• Developmental Biology
• Neuroscience
• Lymphatic System
• +3 more

Marina Venero Galanternik is an Assistant Professor at the University of Utah 's Department of Human Genetics. Her research focuses on meningeal development, lymphatic systems, and neurovascular interactions using zebrafish as a model organism due to their optical accessibility for high-resolution imaging. B.S. from Universidad Nacional Agraria La Molina Ph.D. from University of Utah Her work investigates meningeal dysfunction in diseases like meningitis and age-related neurodegeneration, leveraging zebrafish's transparent skull to study cellular and molecular mechanisms. Recent publications highlight anatomical discoveries, lymphatic pathophysiology, and innovative imaging techniques. Key collaborations include research with Dr. Brant M. Weinstein's lab, focusing on: Developmental pathways in meningeal and lymphatic systems Non-cell-autonomous signaling in collective cell migration Comparative neuroanatomy between zebrafish and mammals Contact: marina.venero@genetics.utah.edu

Nancy J. RuschView profile

Professor

• Calcium Channels
• Potassium Channels
• Hypertension
• +3 more

Nancy J. Rusch is a Distinguished Professor and Chair of the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. She holds a Ph.D. from the Mayo Clinic (1983). Her research focuses on ion channel abnormalities in hypertension, particularly calcium and potassium channels in vascular muscle cells, with a goal to identify channel-based therapies for systemic and pulmonary hypertension. She employs molecular, cellular, and in vivo techniques in her investigations. Recent research grants include NIH R01 grants (e.g., R01 HL097107), AHA Predoctoral Fellowships, and collaborations with institutions like PhRMA and the Arkansas CCTR. She has advised students such as Shrum, Stolarz AJ, and Detweiler ND, contributing to studies on lymphatic dysfunction, renal transplantation, and channel therapies. Key areas of study include mitochondrial BK channel roles in renal preservation, doxorubicin-induced lymphostasis, and leptin’s impact on obesity-related hypertension. Her work bridges basic science with translational medicine, aiming to improve vascular health outcomes.

• Drug Delivery
• Lymphatic Biology
• Pharmacokinetics
• +4 more

Dr. Natalie Trevaskis is an Associate Professor at Monash University's Faculty of Pharmacy and Pharmaceutical Sciences and Head of the Lymphatic Medicine Laboratory at the Monash Institute of Pharmaceutical Sciences. Her work focuses on lymphatic dysfunction in diseases like arthritis, pancreatitis, and metabolic disorders, and developing lymph-targeted drug delivery systems. She holds an H-index of 27 and over 65 publications in top journals, including Nature and Nature Metabolism. Dr. Trevaskis has secured patents for lipid prodrugs licensed to Puretech Health and Boehringer Ingelheim. Education: BPharm (Gold Medal, 2001), PhD (Mollie Holman Medal, 2006), Monash University. Research Interests: Lymphatic biology, drug delivery systems (liposomes, lipoproteins), metabolic diseases, and immunology. Her lab includes 2 postdocs, 7 PhD students, and 2 honours students. She has supervised 13 completions, with students winning international awards. Dr. Trevaskis is a sought-after speaker, presenting at conferences like the International Lymphatic Forum and Gordon Research Conferences. Teaching Roles: Unit coordinator for PHR1022/PHR2021 in Master of Pharmacy programs, lecturing on drug delivery and pharmacokinetics. Her professional roles include serving on the MIPS Animal Ethics Committee, editorial boards for Pharmaceutical Research and Journal of Pharmaceutical Science, and leading initiatives like the Melbourne Lymphatic Symposium since 2016.

Tarja MalmView profile

Professor

• Neuroinflammation
• Neurodegenerative diseases
• Microglial biology
• +7 more

Tarja Malm is a Professor at the University of Eastern Finland (UEF), affiliated with the A.I. Virtanen Institute for Molecular Sciences under the Faculty of Health Sciences. She leads the Neuroinflammation research group, focusing on understanding microglial dysfunctions in neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her work integrates molecular biology, environmental toxicology, and computational approaches to explore mechanisms underlying neurodegeneration and neuroinflammation. Key research interests include the role of extracellular vesicles, epigenetic regulation, and environmental factors (e.g., air pollution) in disease progression. She has contributed to identifying therapeutic targets, such as endocannabinoid system modulation and genetic variants like PLCγ2-P522R, which influence microglial activity. Her projects, including MINERVA and Neuro-Innovation, address translational research challenges in neurodegenerative diseases. Recent publications highlight her work on air pollution-induced neurotoxicity, molecular mechanisms of protein aggregation, and AI-driven image analysis for neuronal structures. Despite extensive research output, no specific scientific awards are mentioned. Malm collaborates with multidisciplinary teams, including projects on microglia modeling and environmental health impacts. Her lab is part of broader initiatives like the TUBE Project, investigating ultrafine particle effects on brain health.

• Liver Biology
• Vascular Biology
• Liver Fibrosis
• +8 more

Yasuko Iwakiri, Ph.D., is a Professor of Medicine (Digestive Diseases) at Yale School of Medicine, affiliated with the Department of Medicine (Digestive Diseases). Her research focuses on liver vascular biology, including lymphatic systems, fibrosis mechanisms, and alcohol-induced liver disease. She leads the Iwakiri Lab, investigating hepatic stellate cells, Kupffer cells, and therapeutic nanoparticle delivery. Key contributions include studies on Nogo-B protein’s role in fibrosis and lymphangiogenesis’s protective effects. Dr. Iwakiri is a recipient of awards such as the Samuel D. Kushlan Award and holds editorial roles in journals like Hepatology Communications. Research Interests: Her work bridges basic science and translational medicine. Major areas include vascular biology of the liver, fibrosis pathogenesis, and alcohol-related liver injury. She explores novel therapeutic approaches using nanoparticles targeting specific liver cells. Notable findings include the sympathetic nervous system’s role in hepatic lymphangiogenesis and mechanisms of liver sinusoidal endothelial dysfunction in alcohol-related diseases. Publications: Over 120 peer-reviewed articles highlight her contributions to understanding liver lymphatics, fibrosis, and disease models. Recent work includes guidelines on portal hypertension and studies on IL-7-based identification of liver lymphatic cells. Awards and Honors: Samuel D. Kushlan Junior Faculty Award (2012) Clinical and Translational Scholar Award (2007) National Research Awards (2000–2005) Lab and Collaborations: The Iwakiri Lab collaborates with departments like Biomedical Engineering and Oncology. Key partners include Dr. Mark Saltzman (nanoparticle research) and Dr. William Sessa (vascular biology).

• Neuroimaging
• Stroke Research
• Neurovascular Coupling
• +7 more

Basavaraju Sanganahalli is a Research Scientist in Radiology & Biomedical Imaging at Yale School of Medicine, directing the Small Animal MRI Core in the Magnetic Resonance Research Center. His expertise combines neurophysiology with fMRI to study brain function in health and disease. He holds a PhD in Neuroscience (2004) from National Institute of Mental Health and Neurosciences, along with advanced training in Biophysics and Physics. Research focuses on neurovascular coupling, stroke mechanisms, Alzheimer’s disease, spinal cord injury, and preclinical model development. His work integrates advanced imaging techniques like fMRI with electrophysiological and molecular approaches. Key contributions include understanding cerebroprotective therapies, microglial dysfunction in early adversity, and genotype-dependent Alzheimer’s interventions. Publications emphasize translational research in stroke treatment efficacy (e.g., uric acid cerebroprotection), neuroinflammation modulation (VEGF-C studies), and functional connectivity analysis in rodent models. Collaborations span Yale’s Magnetic Resonance Research Center, Bioimaging Sciences, and clinical neurology teams. Current projects include multi-center preclinical stroke trials (SPAN Trial), APOE genotype-dependent therapies, and developing standardized neuroimaging protocols for rodent brain studies. His work bridges basic science with clinical applications in neurology and neurodegenerative diseases.

• Ophthalmology
• Neuroscience
• Immunology
• +3 more

Dr Yashar Seyed Razavi is an Honorary Senior Lecturer in the School of Medical Sciences at the University of Sydney, affiliated with the Save Sight Institute. His research focuses on neuro-immune interactions in ocular tissues, particularly investigating corneal pain mechanisms, fibrosis, and imaging techniques. Key areas include developing animal models (e.g., JR5558 mice, ciliary nerve constriction) to study retinal and corneal pathologies. Research Interests: Dr Razavi explores the interplay between nerves and immune cells in diseases such as dry eye syndrome, neuropathic corneal pain, and retinal fibrosis. He employs advanced imaging technologies like multiphoton microscopy to visualize cellular interactions. His work also examines molecular signaling pathways (e.g., Notch signaling) and therapeutic interventions using nerve growth factors. Publications Trends: Recent articles emphasize corneal nerve dysfunction, dendritic cell modulation, and model validation. His work bridges basic science and translational medicine, aiming to improve diagnostic and therapeutic strategies for ocular disorders. Awards: None explicitly listed in available texts. Advising & Grants: No specific grants or student advisees mentioned. Research activities are likely supported through institutional collaborations. Labs/Teams: Active in the Save Sight Institute, focusing on ophthalmic research and neuro-immunological studies.

Synnøve YndestadView profile

Researcher

• Breast Cancer
• Oncology
• Molecular Biology
• +3 more

Synnøve Yndestad is a Researcher at the Department of Clinical Science, University of Bergen, affiliated with Haukeland University Hospital. Her work focuses on molecular mechanisms underlying breast cancer, particularly the roles of PTEN, BRCA1, and related signaling pathways. She investigates genetic and epigenetic factors influencing tumor behavior and treatment response, including homologous recombination deficiency, Akt signaling, and pseudogene functions. Yndestad has contributed to clinical trials evaluating targeted therapies like olaparib for triple-negative breast cancer, as well as studies on germline variants in pediatric sarcomas and the impact of lymphatic dysfunction on cancer progression. She holds a doctoral dissertation on PTEN’s role in breast cancer and has published extensively in high-impact journals such as JCO Precision Oncology and Molecular Cancer Research .

James CroninView profile

Associate Professor

• Cancer Metabolism
• Innate Immunity
• Inflammation
• +3 more

Dr. James Cronin is an Associate Professor in Biomedical Sciences at Swansea University Medical School. He holds an honorary role as Co-Director of Post-Graduate Research. His academic journey includes a BSc in Medical Microbiology from King’s College London, an MSc from Cardiff University, and a PhD from Swansea University investigating inflammation’s role in throat cancer progression. Dr. Cronin’s research focuses on cancer metabolism, innate immunity, and chronic inflammatory diseases, particularly targeting aberrant cell signaling pathways. He leads a group exploring therapies to combat chemotherapy resistance and inflammation-driven diseases. His teaching spans Human Immunology, Medical Genetics, and Cancer Immunotherapy at undergraduate and postgraduate levels. Key research interests include immunometabolic adaptations in pregnancy, ferroptosis in cancer, and nanomedicine applications. Collaborations span veterinary and human health, with a strong emphasis on translational research. His work has been published in high-impact journals such as Nature Communications and Allergy, with a focus on metabolic reprogramming and immune cell function. Dr. Cronin supervises PhD students in areas like ferroptosis induction, ovarian cancer metabolism, and drug repurposing. He is affiliated with the Institute of Life Science and actively contributes to interdisciplinary research teams.

Indika EdirisingheView profile

Professor

• Nutrition Science
• Food Science
• Vascular Biology
• +4 more

Indika Edirisinghe is a Professor of Food Science and Nutrition and Associate Director of the Center for Nutrition Research at Illinois Institute of Technology (IIT). He holds a PhD from the University of Peradeniya (Sri Lanka), an M.Phil. from the same institution, and a B.Sc. from the University of Delhi (India). His research focuses on the impact of dietary components on vascular disease, particularly investigating endothelial function, oxidative stress, and inflammatory responses through in vivo human studies and in vitro models. He is affiliated with professional organizations including the Society of Free Radical Biology and Medicine and the American Physiological Society. Edirisinghe has served on national and international panels, including the NIH Special Emphasis Panel and Benedictine University's MPH Program Advisory Board. His publications explore topics like the effects of processed tomato products, anthocyanins from berries, and grape seed extracts on cardiovascular health markers. His work bridges food science with clinical outcomes, emphasizing translational nutrition research. He advises on food traceability technologies, advocating for AI-driven systems to meet FDA regulations. Media appearances highlight his studies on mangoes' impact on diabetes risk and the role of technology in food safety. His lab focuses on molecular mechanisms linking diet to chronic diseases, with a commitment to advancing evidence-based nutritional strategies.

Amanda StolarzView profile

Assistant Professor

• Cardiovascular Pharmacology
• Lymphatic System
• Translational Pharmacology
• +6 more

Amanda Stolarz, Pharm.D., Ph.D., is an Assistant Professor at the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy, Department of Pharmaceutical Sciences. Her research focuses on cardiovascular/lymphatic pharmacology, particularly the impact of cancer chemotherapy on lymphatic integrity and the development of therapeutic strategies to mitigate this damage. She also investigates the effects of cardiovascular drugs on lymphatic function, linking hypertension treatment to lymphedema risk in cancer patients. Education: B.S. in Chemistry (Arkansas Tech University), Pharm.D. (UAMS College of Pharmacy), Ph.D. in Pharmacology (UAMS Graduate School), Postdoctoral Fellowship in Pharmacology/Toxicology (UAMS). Teaching: Pharmacology I (PHSC 7201). Her research integrates hypothesis-driven approaches with techniques including tissue dissection, flow cytometry, vascular functional studies, gene/protein expression assays, surgical lymph flow measurement, and high-speed optical imaging. Key areas include chemotherapy-induced lymphatic damage, antihypertensive drug effects, and lymphedema mechanisms. Recent publications highlight her work on lymphatic flow preservation, drug-induced lymphatic dysfunction, and imaging methodologies. Collaborations with researchers like Rusch NJ and Zharov VP emphasize interdisciplinary translational studies. While no awards or grants are explicitly detailed, her lab's focus on pharmacological interventions and lymphatic physiology underscores her contributions to drug development and vascular health.

• Lung Transplantation
• Respiratory Diseases
• Thoracic Surgery
• +4 more

Robin Vos serves as an Associate Professor at KU Leuven's Faculty of Medicine, where he is affiliated with the Department of Chronic Diseases and Metabolism and the Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE). He is also a member of Leuven.IRD - KU Leuven Institute for Rare Diseases and participates in institutional governance as a member of both the Council of the Faculty of Medicine and the Council of the Department of Chronic Diseases and Metabolism. Dr. Vos's research focuses primarily on lung transplantation, with particular expertise in chronic lung allograft dysfunction, lymphatic system involvement in transplantation, and the impact of donor/recipient aging on transplant outcomes. His work bridges clinical practice and laboratory research, with significant emphasis on improving graft acceptance and understanding the physiological changes following lung transplantation. Analysis of his recent publications reveals a strong concentration on practical clinical challenges in lung transplantation, including management of right ventricular function, handling complications like infarction, optimizing donor organ utilization (including from elderly donors), and addressing infection management in transplant recipients. His research increasingly incorporates advanced methodologies including computational modeling for disease understanding. Dr. Vos actively supervises numerous research projects, serving as principal investigator or co-investigator on grants extending through 2030, with particular focus on the OLYMPUS project investigating lymphatics in lung transplantation. His research portfolio demonstrates consistent funding and institutional support for his specialized work in pulmonary transplantation. Within the clinical and academic environment, Dr. Vos contributes to the Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), which appears to be a multidisciplinary research unit investigating various aspects of respiratory pathophysiology, transplantation, and surgical interventions. His work frequently involves collaboration with the University Hospital Leuven's transplant team.

Tine Veronica KarlsenView profile

Associate Professor

• Vascular Physiology
• Lymphatic System
• Interstitial Fluid Dynamics
• +7 more

Tine Veronica Karlsen is an Associate Professor at the Department of Biomedicine, University of Bergen, Norway. She is affiliated with the Cardiovascular Research and Translational Cancer and Vascular Research groups, where her work focuses on vascular physiology, lymphatic function, and interstitial fluid dynamics. Her research explores the pathophysiology of edema, sodium homeostasis, and the role of the lymphatic system in health and disease. Research Interests: Vascular and lymphatic physiology Interstitial fluid regulation and edema formation Sodium storage and hypertension Tumor microenvironment and drug delivery Microvascular permeability and endothelial barrier function Her recent publications reveal a strong trend in understanding how high salt intake affects skin and muscle physiology, with implications for hypertension and inflammatory diseases like psoriasis. She has pioneered minimally invasive imaging techniques to quantify lymph flow using near-infrared-labeled albumin. Her work spans from basic animal models to translational applications in cancer and cardiovascular disease. Scientific Awards: No awards listed in the provided text. Advising and Grants: Dr. Karlsen has supervised master’s students, including Anne Tofteberg, whose thesis focused on lymphatic function in VEGF-C overexpressing mice. She has participated in research funded by the Research Council of Norway (Project Reference: 262079), indicating active grant involvement. Her collaborative network includes institutions such as Vanderbilt University, Charité - Universitätsmedizin Berlin, and SINTEF. Labs and Teams: She is an integral member of the Cardiovascular Research group at the Department of Biomedicine, University of Bergen. Her experimental work involves animal models, micropuncture techniques, and advanced imaging to study interstitial fluid and lymphatic function.